Please assess the completion status of the following clinical trial:

Trial Title: Fluoxetine on Motor Rehabilitation After Ischemic Stroke

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women aged from 18 to 85~* No motor relapse from a previous stroke~* Inclusion from day 5 to day 10 after stroke~* Ischemic stroke with unilateral motor deficit~* Motor NIHSS ≥ 5 on the affected side of the body~* NIHSS \< 20~* Fugl Meyer Motor Scale \<55~* Modified Rankin Scale between 1 and 5~* Informed consent obtained from the subject or a member of his family~Exclusion Criteria:~* Pregnant or breast-feeding woman~* Woman able to procreate without valid contraception~* Subject protected by law~* Concomitant disease with unfavourable prognosis within 1 year~* Drug addiction~* Allergy to fluoxetine~* Hepatic failure (TGO and TGP \>2N)~* Permanent Renal failure (Creatinin \>180micromol/l)~* Patients treated by tricyclic antidepressant, selective serotonin reuptake inhibitor, monoamine oxidase inhibitor (IMAO), and neuroleptics in the past month~* Depression requiring pharmacological treatment~* Previous stroke with motor relapse~* Fugl Meyer Motor Scale \> 55~* Modified Rankin Scale = 0 or 6~* Patients needing carotid surgery within 3 months~* Aphasia preventing correct evaluation of motor and depression scales.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): fluoxetine
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).